During the past decade, Saitama Cancer Center conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 10 clinical trials were completed, i.e. on
average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saitama Cancer Center" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Daiichi Sankyo, Inc." with 4 trials
sponsored, "Incyte Corporation" with 4 trials sponsored, "BeiGene" with 3 trials sponsored and "Daiichi Sankyo Co., Ltd."
with 3 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Cancer Center"
#1 collaborator was "AstraZeneca" with 5 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "Alpha-A, Inc." with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Saitama Cancer Center
According to Clinical.Site data, the most researched conditions in "Saitama Cancer Center" are
"Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Epithelial Ovarian Cancer" (2 trials), "Head and Neck Cancer" (2 trials) and "Non-small Cell Lung Cancer (NSCLC)" (2 trials). Many other conditions were trialed in "Saitama Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Saitama Cancer Center
Most popular intervention types in "Saitama Cancer Center" are "Drug" (43 trials), "Other" (3 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (9 trials), "Cisplatin" (6 trials), "Placebo" (6 trials), "Carboplatin" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Saitama Cancer Center
The vast majority of trials in "Saitama Cancer Center" are
39 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Saitama Cancer Center
Currently, there are NaN active trials in "Saitama Cancer Center".
undefined are not yet recruiting,
15 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Saitama Cancer Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Cancer Center, 4 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".